CP

Caligan Partners

North America, New York, United States, New York

Description

Caligan Partners is an investment advisory firm.

Investor Profile

Caligan Partners has backed more than 6 startups, with 2 new investments in the last 12 months alone. The firm has led 4 rounds, about 67% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.
  • Led 1 rounds in the past year.

Stage Focus

  • Post Ipo Equity (83%)
  • Series A (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Biopharma
  • Pharmaceutical
  • Nanotechnology
  • Manufacturing
  • Medical
  • Medical Device
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Caligan Partners frequently co-invest with?

Altium Capital
North America, New York, United States, New York
Co-Investments: 1
Innocreative Capital
North America, California, United States, Woodland Hills
Co-Investments: 1
GH
Asia, Amman, Jordan, Amman
Co-Investments: 1
Woodline Partners
North America, California, United States, San Francisco
Co-Investments: 1
Sphera Global Healthcare Fund
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Great Point Partners
North America, Connecticut, United States, Greenwich
Co-Investments: 1
VC
North America, Georgia, United States, Alpharetta
Co-Investments: 1
Schonfeld Strategic Advisors
North America, New York, United States, New York
Co-Investments: 1
Armistice Capital
North America, New York, United States, New York
Co-Investments: 1
SV
North America, North Carolina, United States, Cary
Co-Investments: 1

Which angels does Caligan Partners often collaborate with?

PM
North America, Virginia, United States, Charlottesville
Shared Deals: 1
RJ
North America, North Carolina, United States, Chapel Hill
Shared Deals: 1

What are some of recent deals done by Caligan Partners?

Vor Biopharma

Cambridge, Massachusetts, United States

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

BiotechnologyHealth CareOncologyPharmaceutical
Post Ipo EquityJun 24, 2025
Amount Raised: $175,000,000
Liquidia Technologies

Morrisville, North Carolina, United States

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

BiopharmaBiotechnologyHealth CareNanotechnologyTherapeutics
Post Ipo EquitySep 11, 2024
Amount Raised: $67,500,000
Anika Therapeutics

Bedford, Massachusetts, United States

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its

BiotechnologyHealth CareManufacturingTherapeutics
Post Ipo EquityMar 7, 2024
Outlook Therapeutics

Iselin, New Jersey, United States

Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityJan 23, 2024
Amount Raised: $65,000,000
Teal Bio

Somerville, Massachusetts, United States

Teal Bio offers a respirator system that is designed to be reusable and easily disinfected.

Health CareMedicalMedical Device
Series ANov 22, 2021
Amount Raised: $3,000,000
Liquidia Technologies

Morrisville, North Carolina, United States

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

BiopharmaBiotechnologyHealth CareNanotechnologyTherapeutics
Post Ipo EquityApr 13, 2021
Amount Raised: $21,700,000